1Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
2Touro University Nevada, Henderson, Nevada; and.
J Natl Compr Canc Netw. 2020 Jun;18(6):747-754. doi: 10.6004/jnccn.2019.7385.
National guidelines recommend regular measurement of functional status among patients with cancer, particularly those who are elderly or high-risk, but little is known about how functional status relates to clinical outcomes among hospitalized patients with advanced cancer. The goal of this study was to investigate how functional impairment is associated with symptom burden and healthcare utilization and clinical outcomes.
We conducted a prospective observational study of patients with advanced cancer with unplanned hospitalizations at Massachusetts General Hospital from September 2014 through March 2016. Upon admission, nurses assessed patients' activities of daily living (ADLs; mobility, feeding, bathing, dressing, and grooming). Patients with any ADL impairment on admission were classified as having functional impairment. We used the revised Edmonton Symptom Assessment System (ESAS-r) and Patient Health Questionnaire-4 to assess physical and psychological symptoms, respectively. Multivariable regression models were used to assess the relationships between functional impairment, hospital length of stay, and survival.
Among 971 patients, 390 (40.2%) had functional impairment. Those with functional impairment were older (mean age, 67.18 vs 60.81 years; P<.001) and had a higher physical symptom burden (mean ESAS physical score, 35.29 vs 30.85; P<.001) compared with those with no functional impairment. They were also more likely to report moderate-to-severe pain (74.9% vs 63.1%; P<.001) and symptoms of depression (38.3% vs 23.6%; P<.001) and anxiety (35.9% vs 22.4%; P<.001). Functional impairment was associated with longer hospital length of stay (β = 1.29; P<.001) and worse survival (hazard ratio, 1.73; P<.001).
Hospitalized patients with advanced cancer who had functional impairment experienced a significantly higher symptom burden and worse clinical outcomes compared with those without functional impairment. These findings provide evidence supporting the routine assessment of functional status on hospital admission and using this to inform discharge planning, discussions about prognosis, and the development of interventions addressing patients' symptoms and physical function.
国家指南建议定期测量癌症患者的功能状态,尤其是那些老年或高危患者,但对于功能障碍与晚期癌症住院患者的症状负担、医疗保健利用和临床结局之间的关系知之甚少。本研究旨在探讨功能障碍与症状负担和医疗保健利用以及临床结局之间的关系。
我们对 2014 年 9 月至 2016 年 3 月在马萨诸塞州综合医院接受计划外住院治疗的晚期癌症患者进行了前瞻性观察研究。入院时,护士评估了患者的日常生活活动(ADL;移动、进食、洗澡、穿衣和修饰)。入院时任何 ADL 受损的患者被归类为有功能障碍。我们分别使用修订后的埃德蒙顿症状评估系统(ESAS-r)和患者健康问卷-4 来评估身体和心理症状。多变量回归模型用于评估功能障碍、住院时间和生存之间的关系。
在 971 名患者中,390 名(40.2%)有功能障碍。与无功能障碍的患者相比,有功能障碍的患者年龄更大(平均年龄,67.18 岁 vs 60.81 岁;P<.001),身体症状负担更重(平均 ESAS 身体评分,35.29 分 vs 30.85 分;P<.001)。他们也更有可能报告中度至重度疼痛(74.9% vs 63.1%;P<.001)、抑郁症状(38.3% vs 23.6%;P<.001)和焦虑症状(35.9% vs 22.4%;P<.001)。功能障碍与住院时间延长(β=1.29;P<.001)和生存状况恶化(风险比,1.73;P<.001)相关。
与无功能障碍的患者相比,功能障碍的晚期癌症住院患者的症状负担更高,临床结局更差。这些发现为入院时常规评估功能状态提供了证据支持,并利用这一证据为出院计划、预后讨论以及解决患者症状和身体功能的干预措施的制定提供信息。